Cannabis Provider Due Diligence: Records, Services, and Limits
Evaluate any cannabis source by checking current legal scope, exact product and batch records, laboratory categories and limits, written service terms, privacy practices, referral boundaries, and the provider’s actual credentials. Business model, company terminology, extraction method, consultation availability, or a passing laboratory panel does not establish purity, safety, superiority, efficacy, treatment benefit, individual medical fit, product selection, dosing, or predictable response.
Verify identity and legal scope
Confirm the business name, contact information, credentials, and any license required for the activity and location. Check where products may legally be sold or shipped, and verify current rules through the relevant government source rather than relying on a sales statement.
Match the exact product to its records
Match the product name, lot or batch number, laboratory, report identifier, test date, cannabinoid amounts and units, ingredients, tested categories, results, and applicable limits. A report describes the tested sample within the categories and limits shown. Treat an absent category as unresolved rather than proof that a substance is absent.
Separate terminology from proof
Terms such as full-spectrum, FECO, clean, medical grade, or premium require a clear definition. Extraction method and chemical profile can describe disclosed process information or a tested sample, but they do not establish complete purity, safety, superiority, efficacy, or individual medical fit.
Confirm the service scope
Ask what education, records, consultation time, and follow-up are included; whether fees and refund terms are written; how consent and privacy are handled; what credentials staff hold; and which questions are referred to qualified clinicians or pharmacists. Compare providers using the same questions and documented terms.
Know the clinical boundaries
Medicine interactions, medical suitability, product selection, dosing, monitoring, medication changes, and individualized treatment decisions belong with a qualified clinician or pharmacist. Urgent or serious concerns require appropriate medical care.
Applying the checklist to King Harvest
King Harvest describes consultations and product education at its consultation page and explains company terminology in its FECO overview. Those pages describe the company’s stated services and terminology. They are not independent evidence of efficacy, safety, medical suitability, or predictable response.
Frequently Asked Questions
What records should be matched to the exact cannabis product?
Match the product name, lot or batch number, laboratory, report identifier, test date, cannabinoid amounts and units, ingredients, tested categories, results, and applicable limits.
Does extraction terminology or a passing laboratory panel prove overall quality or medical suitability?
No. Those records describe disclosed process information or a tested sample within stated categories and limits; they do not establish complete purity, safety, superiority, efficacy, or individual medical fit.
What service questions should be asked before relying on a provider?
Ask what education, records and follow-up are included; how consent and privacy are handled; what fees and refund terms apply; what credentials staff hold; and which questions are referred to qualified clinicians or pharmacists.
Who should address medicine interactions, product selection, dosing, monitoring, or treatment?
A qualified clinician or pharmacist should address medicine interactions, medical suitability, product selection, dosing, monitoring, medication changes, and individualized treatment decisions.
Important: This is general education, not medical or legal advice. Follow applicable law and current product warnings.

